Literature DB >> 18823302

Macrolide-theophylline interactions: no role for the inhibition of cytochrome P4501A2.

Thomas M Polasek, John O Miners.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18823302      PMCID： PMC2675765          DOI： 10.1111/j.1365-2125.2008.03299.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  19 in total

Review 1.  Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin.

Authors:  J F Westphal
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

2.  Effect of calcium channel blockers on theophylline disposition.

Authors:  S M Sirmans; J A Pieper; R L Lalonde; D G Smith; T H Self
Journal:  Clin Pharmacol Ther       Date:  1988-07       Impact factor: 6.875

3.  Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms.

Authors:  W Tassaneeyakul; D J Birkett; M E McManus; W Tassaneeyakul; M E Veronese; T Andersson; R H Tukey; J O Miners
Journal:  Biochem Pharmacol       Date:  1994-05-18       Impact factor: 5.858

4.  Theophylline metabolism in human liver microsomes: inhibition studies.

Authors:  J F Tjia; J Colbert; D J Back
Journal:  J Pharmacol Exp Ther       Date:  1996-03       Impact factor: 4.030

5.  Theophylline has no advantages over caffeine as a putative model drug for assessing CYPIA2 activity in humans.

Authors:  B B Rasmussen; K Brøsen
Journal:  Br J Clin Pharmacol       Date:  1997-03       Impact factor: 4.335

6.  Effect of ketoconazole on hepatic oxidative drug metabolism.

Authors:  M W Brown; A L Maldonado; C G Meredith; K V Speeg
Journal:  Clin Pharmacol Ther       Date:  1985-03       Impact factor: 6.875

7.  Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies.

Authors:  Sonja Eberl; Bertold Renner; Antje Neubert; Mareike Reisig; Iouri Bachmakov; Jörg König; Frank Dörje; Thomas E Mürdter; Andreas Ackermann; Harald Dormann; Karl G Gassmann; Eckhart G Hahn; Stefanie Zierhut; Kay Brune; Martin F Fromm
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

8.  Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies.

Authors:  R A Robson; J O Miners; A P Matthews; I Stupans; D Meller; M E McManus; D J Birkett
Journal:  Biochem Pharmacol       Date:  1988-05-01       Impact factor: 5.858

9.  Lacking effect of grapefruit juice on theophylline pharmacokinetics.

Authors:  U Fuhr; A Maier; A Keller; V W Steinijans; R Sauter; A H Staib
Journal:  Int J Clin Pharmacol Ther       Date:  1995-06       Impact factor: 1.366

Review 10.  Pharmacokinetic drug interactions of macrolides.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447
View more
  1 in total

1.  Perpetrators of pharmacokinetic drug-drug interactions arising from altered cytochrome P450 activity: a criteria-based assessment.

Authors:  Thomas M Polasek; Frank P Y Lin; John O Miners; Matthew P Doogue
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.